$CGC

Canopy Growth Corp (CGC) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. On September 25, 2026, Canopy Growth Corporation (“ Canopy Growth ”) convened and adjourned to, and reconvened on, October 23, 2026, its 2026 Annual General and Special Meeting of Shareholders (the “ Annual Meeting ”

Canopy Growth shareholders approved a reverse stock split, board elections, and other governance measures. The company received authority to consolidate shares within a specified range. All proposals, including executive compensation and an annual say-on-pay vote, passed. Final voting results will be reported via SEDAR+, a press release, and a Form 8-K filing.

Canopy Growth (CGC) shares fell due to delays in U.S. marijuana rescheduling. The DEA temporarily stayed the process, awaiting responses. Canopy's larger issues include Canadian market challenges and operating losses, with a $300M valuation and a $200M equity program.

Canopy Growth (CGC) received a notice from Nasdaq for failing to meet the $1.00 minimum bid price requirement for 30 consecutive days. The company has until April 12, 2027, to comply, potentially through a reverse stock split. The notice does not immediately affect its Nasdaq listing, and its TSX listing remains unaffected.

Canopy Growth (TSX:WEED, NASDAQ:CGC) announced its Smiths Falls, Ontario facility received EU GMP certification, covering softgel and cannabis flower production. The company claims it's the only Canadian facility with this combined scope certification. This supports medical cannabis supply to Europe, aligning with its expansion strategy in Germany, Poland, and the UK. The certification follows a similar one for its Kincardine facility.

Insider transactions occurred at Oracle, Alibaba, Costco, Palo Alto Networks, Canopy Growth, GameStop, and Simon Property Group. Notable sales included Alibaba's CFO selling 103,046 shares and Costco's EVP selling 2,200 shares. Significant purchases were made by Oracle's director and GameStop's CEO. Transactions occurred between September 27 and October 2, with varying percentages of holdings sold or bought.

Canopy Growth reported Q1 fiscal 2027 revenue of $57.4M, up 13% YoY, with growth across all major businesses. Adjusted EBITDA loss narrowed to $2.3M, down 59% YoY. Management expects positive EBITDA in fiscal 2027, driven by integration of MTL Cannabis and cost savings. Free cash flow worsened to $18.5M, but the company has $241.4M in cash and extended debt maturities to 2031.

Canopy Growth (CGC) is considering another reverse stock split after its shares fell below $1, risking delisting. The company's shares dropped 80% since its last reverse split in December 2023. A shareholder vote on the new split is scheduled for September 25. Canopy reported a 13% sales growth in Q1 2027, with a 68% reduction in losses year-over-year.

Canopy Growth (TSE: WEED, NASDAQ: CGC) will supply four medical cannabis strains to the UK market via GROW Group. This expands its international reach, with Europe contributing 12% of its Q2 revenue. Shares trade near 52-week lows. The company reported a narrowed adjusted loss and increased international revenue, driven by Poland. Competitors Aurora and Tilray have entered the UK market through acquisitions.

Insiders sold shares in CrowdStrike (CRWD), Uber (UBER), Snowflake (SNOW), Canopy Growth (CGC), and Medtronic (MDT) last week. CrowdStrike director Roxanne Austin sold 50,000 shares for $11.88M. Uber's Jill Hazelbaker sold 28,170 shares for $2.01M. Snowflake's Jonathan Beaulier sold 12,292 shares for $4.13M. Devon Energy (DVN) CEO Clay Gaspar bought 3,913 shares for $199,876. FuelCell Energy (FCEL) director John Livingston bought 16,404 shares for $246,955.